These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25623427)

  • 1. Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.
    Ding X; Yang DR; Xia L; Chen B; Yu S; Niu Y; Wang M; Li G; Chang C
    Mol Cancer; 2015 Jan; 14(1):16. PubMed ID: 25623427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.
    Ding X; Yang DR; Lee SO; Chen YL; Xia L; Lin SJ; Yu S; Niu YJ; Li G; Chang C
    Int J Cancer; 2015 Feb; 136(4):955-64. PubMed ID: 24975468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status.
    Lin SJ; Lin CY; Yang DR; Izumi K; Yan E; Niu X; Chang HC; Miyamoto H; Wang N; Li G; Chang C
    Neoplasia; 2015 Apr; 17(4):339-47. PubMed ID: 25925376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression.
    Zhu J; Yang DR; Sun Y; Qiu X; Chang HC; Li G; Shan Y; Chang C
    Mol Cancer Ther; 2015 Jun; 14(6):1445-53. PubMed ID: 25833838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer.
    Yang DR; Ding XF; Luo J; Shan YX; Wang R; Lin SJ; Li G; Huang CK; Zhu J; Chen Y; Lee SO; Chang C
    J Biol Chem; 2013 Jun; 288(23):16476-16483. PubMed ID: 23609451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR-373-3p expression to alter TGFβR2/p-Smad3 signals.
    Qiu X; Zhu J; Sun Y; Fan K; Yang DR; Li G; Yang G; Chang C
    Oncotarget; 2015 Jun; 6(17):15397-409. PubMed ID: 25980442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
    Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
    Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling.
    Hu S; Li L; Yeh S; Cui Y; Li X; Chang HC; Jin J; Chang C
    Mol Oncol; 2015 Jan; 9(1):44-57. PubMed ID: 25135278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TR
    Jin R; Lin H; Li G; Xu J; Shi L; Chang C; Cai X
    Cell Death Dis; 2018 Feb; 9(3):283. PubMed ID: 29449527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity.
    Chen D; Chou FJ; Chen Y; Tian H; Wang Y; You B; Niu Y; Huang CP; Yeh S; Xing N; Chang C
    Cancer Lett; 2020 Dec; 495():100-111. PubMed ID: 32768524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of miR‑145 and testicular nuclear receptor 4 inhibition to reduce chemoresistance to docetaxel in prostate cancer.
    Zhu J; Qin P; Cao C; Dai G; Xu L; Yang D
    Oncol Rep; 2021 Mar; 45(3):963-974. PubMed ID: 33650661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TR4 nuclear receptor enhances the cisplatin chemo-sensitivity via altering the ATF3 expression to better suppress HCC cell growth.
    Shen J; Lin H; Li G; Jin RA; Shi L; Chen M; Chang C; Cai X
    Oncotarget; 2016 May; 7(22):32088-99. PubMed ID: 27050071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals.
    Xie H; Li L; Zhu G; Dang Q; Ma Z; He D; Chang L; Song W; Chang HC; Krolewski JJ; Nastiuk KL; Yeh S; Chang C
    Oncotarget; 2015 May; 6(14):12326-39. PubMed ID: 25940439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.
    Das SK; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Sarkar D; Emdad L; Fisher PB
    Cancer Res; 2018 Jun; 78(11):2852-2863. PubMed ID: 29572229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finasteride inhibits human prostate cancer cell invasion through MMP2 and MMP9 downregulation.
    Moroz A; Delella FK; Almeida R; Lacorte LM; Fávaro WJ; Deffune E; Felisbino SL
    PLoS One; 2013; 8(12):e84757. PubMed ID: 24386413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells.
    Yu L; Wang CY; Shi J; Miao L; Du X; Mayer D; Zhang J
    Endocrinology; 2011 Mar; 152(3):773-81. PubMed ID: 21248144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenethyl isothiocyanate (PEITC) suppresses prostate cancer cell invasion epigenetically through regulating microRNA-194.
    Zhang C; Shu L; Kim H; Khor TO; Wu R; Li W; Kong AN
    Mol Nutr Food Res; 2016 Jun; 60(6):1427-36. PubMed ID: 26820911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells.
    Dong Z; Nemeth JA; Cher ML; Palmer KC; Bright RC; Fridman R
    Int J Cancer; 2001 Aug; 93(4):507-15. PubMed ID: 11477554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testicular orphan nuclear receptor 4 is associated with the radio-sensitivity of prostate cancer.
    Yu S; Wang M; Ding X; Xia L; Chen B; Chen Y; Zhang Z; Niu Y; Li G; Chang C
    Prostate; 2015 Oct; 75(14):1632-42. PubMed ID: 26178291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testicular orphan receptor 4 promotes tumor progression and implies poor survival through AKT3 regulation in seminoma.
    Chen Y; Lu J; Xia L; Xue D; Yu X; Shen D; Xu L; Li G
    Cancer Sci; 2018 Feb; 109(2):384-394. PubMed ID: 29197138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.